MIF and breast carcinoma: In addition to bioinformatic analysis, MIF assays also showed that the expression strength of PTPRC in breast cancer cells was positively related to CD8 expression strength in breast cancer tissue section (R=0.85, p=1.75e-5, Figures 11B, D).